Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
68.98
-2.71 (-3.78%)
At close: Oct 03, 2025, 3:59 PM
69.10
0.17%
After-hours: Oct 03, 2025, 07:30 PM EDT
-3.78% (1D)
| Bid | 68 |
| Market Cap | 8.07B |
| Revenue (ttm) | 1.18B |
| Net Income (ttm) | 557.28M |
| EPS (ttm) | 4.37 |
| PE Ratio (ttm) | 15.78 |
| Forward PE | 8.85 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 71.7 |
| Volume | 2,623,935 |
| Avg. Volume (20D) | 1,939,130 |
| Open | 71.75 |
| Previous Close | 71.69 |
| Day's Range | 68.04 - 71.84 |
| 52-Week Range | 42.01 - 79.50 |
| Beta | 1.16 |
| Ex-Dividend Date | n/a |
About HALO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HALO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HALO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsHalozyme Therapeutics Inc. is scheduled to release its earnings on
Oct 30, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+2.48%
Halozyme shares are trading higher after the compa...
Unlock content with
Pro Subscription
2 months ago
+1.37%
Halozyme shares are trading higher after the company raised FY25 guidance.
